| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.5 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.5 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |